Intruders in the Brain: What a Pig Model Reveals about Immune Cells in HD

When most people picture scientists doing experiments in labs, they imagine mice in mazes or cells growing in petri dishes. But for complex conditions like Huntington’s Disease (HD), these simple models don’t always capture what’s happening inside the human brain. To bridge this gap, researchers at Jinan University, led by Dr. Sen Yan, turned to a less conventional model organism whose brain more closely resembles our own – pigs! Using a genetically engineered pig model of HD, the team tracked how different types of brain cells change over the course of the disease. They spotted many similarities between pig and human HD brains that are not seen in mice. In addition, their analysis found an intruder from the immune system that might be attacking brain cells  – the cytotoxic T cell. 

From Pigs to Patients

It might sound unusual, but scientists have been using pigs to make exciting advances in biomedical research. Because pig organs are anatomically similar in size and structure to our own, they can be especially useful for studying human disease. In this study, Dr. Yan and his team focused on a specific question: how do brain cell populations change in a pig model of HD, and how do these changes compare to what is seen in people with HD? 

The brain is a complex organ containing many different types of cells. Neurons often get the most attention in HD research because they transmit electrical signals and are the primary cells lost in HD. But many other cell types also change in number as the disease progresses. For example, neuron-support cells called astrocytes, and brain immune cells called microglia, often become more abundant and shift into an unusual ‘activated’ state. These changes are part of a process called neuroinflammation, when microglia and astrocytes begin responding to damaged neurons during disease.

Dr. Yan and his team first investigated how these cellular populations changed in the HD pig’s brain. They found striking similarities to the human brain, some of which were not observed in mouse models of HD. This is exciting because it suggests pigs might better capture key disease-related changes that occur in HD. As expected, they observed a loss of neurons in the striatum, the main brain region affected in HD, alongside an increase in support cells like astrocytes. But one finding that really stood out was the presence of cytotoxic T cells – immune system cells that normally do not have access to the brain. 

Friend or Foe?

Cytotoxic T cells are the big guns of your immune system, responsible for eliminating abnormal cells, such as cancer cells, or those infected with a virus. Despite their scary-sounding name, these cells are absolutely critical for your well-being. In fact, without cytotoxic T cells, even the common cold would be fatal. In this way, cytotoxic T cells are like friendly assassins picking off the traitorous cells of your body. However, given their lethality, they must be tightly restricted and are rarely allowed into the brain. Neurons, the brain’s prized possession, cannot divide or replace themselves, so any accidental fire from T cells could cause permanent damage. 

Considering cytotoxic T cells are normally blocked from entering the brain, Dr. Yan’s team was surprised to find them in the HD pig brain. On closer examination, these friendly assassins did not look so friendly. They were often found next to neurons and actively making proteins used to kill other cells. The researchers did some additional biochemical sleuthing to discover that the T cells were not acting as lone wolves, but rather as a coordinated team of assassins. In other words, they were armed and dangerous whilst mingling with civilian neurons – a recipe for disaster! 

Cytotoxic T cells are not normally able to enter the brain, so how were they getting inside? Under normal conditions, the brain is protected from peripheral immune cells, like cytotoxic T cells, by a structure called the blood-brain barrier. The blood-brain barrier is like a giant wall around all of the brain’s blood vessels that blocks immune cells from entering the brain – unless they are invited in. And that posed a key question – who was inviting these T cells into the brain? The team focused on microglia, the brain’s resident immune cell. They are known to produce signals that give T cells a kind of molecular license to enter the brain. However, these licenses are typically only granted during emergencies to fight brain infections. 

Who Left the Front Door Unlocked?

The researchers analyzed signals released from microglia that might act as a license for T cell entry. They identified a signal called CCL8 floating around, which is well known to attract T cells into the brain. To follow up on this finding, they turned to HD mouse models, which do not show T cells entering the brain. The scientists found that when HD mouse brain cells were genetically engineered to produce CCL8, T cells suddenly began appearing in their brains. 

Furthermore, the appearance of these T cells seemed to worsen neuron loss in the mouse brain. These experiments provided further evidence that CCL8 was opening the door for cytotoxic T cells and that this process could accelerate HD in animal models. 

To test if this pathway could be targeted therapeutically, they used antibodies to bind and neutralize CCL8 in a mouse model. This treatment reversed the entry of T cells into the mouse brain, effectively slamming the door shut to cytotoxic T cells. Although this was not a major focus of the current study, it does point to potential therapeutic avenues for future research. 

A New Pigture of Disease? 

This study raises some important unanswered questions. One question is why microglia are releasing CCL8 in the first place, drawing potentially dangerous cytotoxic T cells into the brain. The scientists did not directly investigate this, but one possibility is that the extra-long huntingtin protein produced in the brain cells of people with HD is being misidentified as foreign by the immune system, triggering an inflammatory response. Another possibility is that, because T cells produce expanded huntingtin protein just like brain cells, the HD mutation could be disrupting their behavior. At this early stage, however, the exact trigger is unclear. 

A second question is whether this pathway could be targeted for therapy. Although the team’s experiments in mice showed that blocking CCL8 reduced T cell entry into the brain and this reduced neuronal damage, these findings are still preliminary. In addition, it’s not known if a similar approach would work in humans. Optimistically, however, it is worth noting that many CCL8 inhibitors currently exist and are used to treat HIV and certain types of cancer. As with many early findings, more work is needed to confirm whether blocking CCL8 reduces T cell entry into the brain, or even whether T cells are destructive in the human HD brain. 

Finally, this study reminds us that how we model a disease shapes what we’re able to see, and what we might be missing. By turning to pigs, researchers uncovered a new layer of biology that could help define the role of the immune system in HD. Models that better mirror the human brain are an important step towards turning promising targets into treatments. 

Summary

• Scientists used a pig model of Huntington’s disease to map how brain cell populations change over the course of disease.
• Pigs showed patterns that more closely resemble the human brain than traditional mouse models.
• As expected, neurons were lost and support cells like astrocytes and microglia increased.
• The researchers also found something unexpected: ‘intruder’ cytotoxic T cells inside the brain, which produced proteins that can damage neurons. 
• Brain immune cells (microglia) were releasing a signal called CCL8, effectively recruiting T cells into the brain.
• When scientists engineered mouse brain cells to produce CCL8, T cells entered the brain and worsened neuron loss, suggesting this pathway could accelerate disease.
• Blocking CCL8 reduced T cell entry, hinting at a possible therapeutic strategy, though more work is needed to understand whether this applies to people.